Alexandria Real Estate Equities shares fall 11.3 percent in rough market session
Updated
Updated · MarketWatch · Apr 28
Alexandria Real Estate Equities shares fall 11.3 percent in rough market session
9 articles · Updated · MarketWatch · Apr 28
The stock closed at $40.41 on Tuesday, marking its second consecutive day of losses and trading 54.2% below its 52-week high.
Trading volume surged to 6.1 million, well above the 50-day average of 2.4 million, as Alexandria underperformed competitors like BXP and Medical Properties Trust.
The broader market also declined, with the S&P 500 down 0.49% and the Dow Jones slipping 0.05%, contributing to Alexandria's sharp drop.
With its stock plunging, will Alexandria Real Estate be forced to cut its dividend?
Is Alexandria Real Estate's 54% stock drop a value trap or a prime buying opportunity?
With Boston's lab vacancy over 30%, what is the future for these specialized buildings?
Why are medical outpatient buildings thriving while advanced life science labs face a crisis?
As AI and cloud labs reshape biotech, is the traditional life science real estate model obsolete?